Exclusive: Antibiotics developer enters into $30.7M partnership to advance its 'anti-superbug agent'https://www.bizjournals.com/philadelphia/news/2019/07/22/antibiotics-developer-venatorx-dod-hhs-superbug.html
2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibiotic
Antibiotic battle against ‘superbugs' taken up by Defense Department, HHShttps://www.modernhealthcare.com/technology/hhs-defense-fund-antibiotic-development-drug-resistant-infections
2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibioticAntibiotic resistance and the development of new drugsUnited States Department of Health and Human Services (HHS)
DHHS, DoD partner with VenatoRx Pharmaceuticals on drug-resistant infection treatment - Homeland Preparedness Newshttps://homelandprepnews.com/stories/35574-dhhs-dod-partner-with-venatorx-pharmaceuticals-on-drug-resistant-infection-treatment/
2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibiotic
HHS, DOD boost superbug fight with $97M investment: 4 things to knowhttps://www.beckershospitalreview.com/quality/hhs-dod-boost-superbug-fight-with-97m-investment-4-things-to-know.html
2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibiotic
HHS, DOD to pay up to $97M to help VenatoRx target superbugs | FierceHealthcarehttps://www.fiercehealthcare.com/hospitals-health-systems/hhs-dod-to-pay-up-to-97m-to-help-venatorx-pharmaceuticals-target-superbugs
2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibiotic
HHS, DoD, VenatoRx Pharmaceuticals to Co-Develop Antibiotichttps://www.hstoday.us/subject-matter-areas/pandemic-biohazard/hhs-dod-venatorx-pharmaceuticals-to-co-develop-antibiotic-to-treat-drug-resistant-infections/
2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibiotic
HHS, DoD, VenatoRx Pharmaceuticals to Co-Develop Novel Antibiotic to Treat Drug-Resistant Infectionshttps://finance.yahoo.com/news/hhs-dod-venatorx-pharmaceuticals-co-130000691.html
2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibiotic
HHS, DoD, VenatoRx Pharmaceuticals to Co-Develop Novel Antibiotic to Treat Drug-Resistant Infections | BioSpacehttps://www.biospace.com/article/releases/hhs-dod-venatorx-pharmaceuticals-to-co-develop-novel-antibiotic-to-treat-drug-resistant-infections/
2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibiotic
HHS, DoD, VenatoRx Pharmaceuticals to co-develop novel antibiotic to treat drug-resistant infectionshttps://www.phe.gov/Preparedness/news/Pages/AMR-DTRA-22July19.aspx
2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibiotic
Stewardship / Resistance Scan for Jul 26, 2019 | CIDRAPhttp://www.cidrap.umn.edu/news-perspective/2019/07/stewardship-resistance-scan-jul-26-2019
2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibiotic

Showing topic

2019-07 Partnership announced between HHS, DoD and VenatoRx to develop VNRX-5133, a new antibiotic
Antibiotic-resistant urinary tract infections (UTIs)Pharmaceutical makers, antibiotic resistance and the development of new drugsUnited States Department of Defense (DoD)United States Department of Health and Human Services (HHS)